News & Events

Akesiss has introduced a new brand Rabipot-LS in their gastro basket. Rabipot-LS is a combination of Rabeprazole and Levosulpiride which offers faster action & sustained relief in Dyspepsia and GERD. Today, millions of Indians are suffering from such acid peptic disorders which makes pharmaceutical companies to invest more in these area. Levosulpiride is an effective prokinetic along with Rabeprazole that provides better relief from such conditions.

The company has introduced two new products into its Gynaecology basket namely “Fopymin Act” and “Elmonea”. “Akesiss has always been the front runner in Gynecology with unique innovations that delivers newer solutions and these two brands will add more value in the management of pregnancy related issues” says Mr. Ashok Kumar, Managing Director – Akesiss pharma. Fopymin Act is the combination of active form of Vitamin B6, B9 and B12 which in indicated in the prevention of pregnancy complications including neural tube defects. Elmonea is indicated in the management of preeclampsia, a condition in pregnancy characterized by high blood pressure, sometimes with fluid retention and proteinuria.
With an objective of strengthening the attachment between each Akesians and their family by sharing the ideas, thoughts, important events in Akesiss and in Akesians family, an inhouse Newsletter titled ‘Yours Truly’ has been launched in April 2015. ‘Yours Truly’ will be a quarterly newsletter that highlights the ways we are bringing our success, innovative ideas, managing work-life balance, various corporate celebrations etc. to make a positive impact among Akesians and their families.

Akesiss is celebrating the completion of 5 glorious years of excellence in healthcare. Akesiss ‘on a health mission with a global vision’ was established in 2009 with an eye to provide high quality medicines at affordable price for better health care. Continuous innovation and unique services have driven us to establish Akesiss as a key health care partner in 5 glorious years. Many landmark achievements have been made in “5 successful years” in terms of infrastructure development, incorporating latest technologies, superior formulations, geographical expansion, unique HR initiatives etc.

Few achievements which have helped us to establish as unique health care partner. 

  • “ISO 9001 : 2008 Certification” from prestigious Bureau Veritas – France & UKAS of UK, within the very first year of launch

  • Presence in 15 therapeutic segments through 6 divisions –Zalvo, Glyvo, Lazo, Carvo, MSD and Critical care

  • Over 60% current growth rate and one of the fastest growing company as reported by IMS (ORG)

  • True Scientific & Academic Partner of more than 90 key scientific conferences

  • More than 75 innovative brands with many ‘first time in India’ products and concepts

  • Unique economic model – introduced many products with affordable prices, mainly in chronic therapeutic segments

Successfully established our identity in the states of Kerala, Karnataka, Tamil Nadu, Andhra Pradesh, Odisha & Maharashtra and we are in the process of ensuring our vision plan as an all India company “It would have never been possible to accomplish this without the support of our doctors, business partners & many industry well-wishers. We sincerely thank all of them for the blessings they have bestowed upon us”, says Mr. Ashok Kumar, Managing Director of Akesiss Pharma.